Related Experiment Video

Updated: Jul 17, 2026

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation
11:07

Inducing Acute Lung Injury in Mice by Direct Intratracheal Lipopolysaccharide Instillation

Published on: July 6, 2019

Long pentraxin 3 in pulmonary infection and acute lung injury

Xiaolin He1, Bing Han, Mingyao Liu

  • 1Thoracic Surgery Research Laboratory, University Health Network Toronto General Research Institute, Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. .

American Journal of Physiology. Lung Cellular and Molecular Physiology
|February 6, 2007
PubMed

Insights

Long pentraxin 3 (PTX3) is an acute phase protein involved in lung infection defense. However, elevated PTX3 can worsen lung injury, necessitating further research into its sources and regulation for targeted therapies.

Area of Science:

  • Immunology
  • Pulmonary Medicine

Background:

  • Long pentraxin 3 (PTX3) is an acute phase protein produced by immune and tissue cells at inflammatory sites.
  • PTX3 plays a dual role in the lung, offering protection against certain pathogens but also potentially exacerbating lung injury under specific conditions.

Purpose of the Study:

  • To investigate the cellular sources and regulatory mechanisms of PTX3 expression in the lung.
  • To elucidate the binding interactions of PTX3 with pathogens, complement, and apoptotic cells.
  • To identify potential PTX3 receptors on target cells.

Main Methods:

  • The abstract does not specify the methods used.
  • Further research is needed to determine PTX3's binding mechanisms and receptor interactions.

Main Results:

  • The abstract does not specify the main results.
  • Increased PTX3 expression is linked to more severe lung injury in conditions like ischemia-reperfusion and severe bacterial infection.

Conclusions:

  • Understanding PTX3's complex role is crucial for developing therapies against pulmonary infections and acute lung injury.
  • Further studies are essential to harness PTX3's protective functions while mitigating its detrimental effects on lung tissue.

More Related Videos

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents04:10

Non-Invasive Endotracheal Administration of Lipopolysaccharide to Induce Acute Lung Injury in Rodents

Published on: December 5, 2025

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...